Literature DB >> 12052564

Spore diffusate isolated from some strains of Aspergillus fumigatus inhibits phagocytosis by murine alveolar macrophages.

Sébastien Bertout1, Catherine Badoc, Michèle Mallié, Jean Giaimis, Jean-Marie Bastide.   

Abstract

Aspergillus fumigatus is a ubiquitous fungus that grows in decaying organic matter. It can cause disease in both immunodeficient and immunocompetent patients by using virulence factors to escape the host defenses. Some of these factors, such as a diffusate, released from the spores of A. fumigatus, have previously been described. This diffusate was demonstrated to inhibit oxidative burst and phagocytosis of coated red blood cells. The present study has shown that this substance can inhibit the phagocytosis of A. fumigatus spores by murine alveolar macrophages (MALU) and evaluated the action of this substance. We quantified phagocytosis by MALU cells with and without diffusate and evaluated the inhibition of phagocytosis by testing diffusates from different strains. We conclude that the spore diffusate of some strains of A. fumigatus can reversibly decrease the ability of alveolar macrophages to ingest A. fumigatus spores.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12052564     DOI: 10.1111/j.1574-695X.2002.tb00578.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  9 in total

1.  LaeA, a regulator of morphogenetic fungal virulence factors.

Authors:  Jin Woo Bok; S Arunmozhi Balajee; Kieren A Marr; David Andes; Kristian Fog Nielsen; Jens C Frisvad; Nancy P Keller
Journal:  Eukaryot Cell       Date:  2005-09

2.  Aspergillus cyclooxygenase-like enzymes are associated with prostaglandin production and virulence.

Authors:  Dimitrios I Tsitsigiannis; Jin-Woo Bok; David Andes; Kristian Fog Nielsen; Jens C Frisvad; Nancy P Keller
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

3.  Correlation between gliotoxin production and virulence of Aspergillus fumigatus in Galleria mellonella.

Authors:  Emer P Reeves; C G M Messina; S Doyle; K Kavanagh
Journal:  Mycopathologia       Date:  2004-07       Impact factor: 2.574

4.  Binding of live conidia of Aspergillus fumigatus activates in vitro-generated human Langerhans cells via a lectin of galactomannan specificity.

Authors:  F Persat; N Noirey; J Diana; M-J Gariazzo; D Schmitt; S Picot; C Vincent
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

5.  The crucial role of the Aspergillus fumigatus siderophore system in interaction with alveolar macrophages.

Authors:  Markus Schrettl; Oumaima Ibrahim-Granet; Sabrina Droin; Michel Huerre; Jean-Paul Latgé; Hubertus Haas
Journal:  Microbes Infect       Date:  2010-07-24       Impact factor: 2.700

6.  Effects of conidia of various Aspergillus species on apoptosis of human pneumocytes and bronchial epithelial cells.

Authors:  F Féménia; D Huet; S Lair-Fulleringer; M C Wagner; J Sarfati; L Shingarova; J Guillot; P Boireau; R Chermette; N Berkova
Journal:  Mycopathologia       Date:  2009-01-01       Impact factor: 2.574

7.  Aspergillus fumigatus LaeA-mediated phagocytosis is associated with a decreased hydrophobin layer.

Authors:  Taylor R T Dagenais; Steve S Giles; Vishukumar Aimanianda; Jean-Paul Latgé; Christina M Hull; Nancy P Keller
Journal:  Infect Immun       Date:  2009-11-16       Impact factor: 3.441

8.  Environmental dimensionality controls the interaction of phagocytes with the pathogenic fungi Aspergillus fumigatus and Candida albicans.

Authors:  Judith Behnsen; Priyanka Narang; Mike Hasenberg; Frank Gunzer; Ursula Bilitewski; Nina Klippel; Manfred Rohde; Matthias Brock; Axel A Brakhage; Matthias Gunzer
Journal:  PLoS Pathog       Date:  2007-02       Impact factor: 6.823

9.  Aspergillus fumigatus Inhibits Pseudomonas aeruginosa in Co-culture: Implications of a Mutually Antagonistic Relationship on Virulence and Inflammation in the CF Airway.

Authors:  Emma Reece; Sean Doyle; Peter Greally; Julie Renwick; Siobhán McClean
Journal:  Front Microbiol       Date:  2018-06-05       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.